Tablet dosage form for buccal absorption of active ingredients
US11096896B2 · kind B2 · utility
1Cited by
10References
24Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 17, 2018 |
| Grant date | Aug 24, 2021 |
| Priority date | — |
| Expiry date | May 17, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a tablet dosage form for buccal absorption of active ingredients comprising a population of particles and an active ingredient to be released in the oral cavity for absorption through the oral mucosa, the population of particles comprising directly compressible (DC) and non-directly compressible (non-DC) sugar alcohol particles, the non-DC particles providing the tablet with a plurality of discrete non-DC areas.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.